CIK 0002036042 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Sionna Therapeutics, Inc.
Sign in to watch- Ticker
- SION
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 617-819-2020
- Business address
- 21 HICKORY DRIVE, SUITE 500, WALTHAM, MA, 02451
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $21,835,018
- in 1 filing
Net −$21,835,018. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-10-28 | RA CAPITAL MANAGEMENT, L.P. Director | Sale | −17,118 | $39.58 | $678K | 2,240,708 |
| 2025-10-28 | RA CAPITAL MANAGEMENT, L.P. Director | Sale | −10,476 | $39.58 | $415K | 209,391 |
| 2025-10-24 | RA CAPITAL MANAGEMENT, L.P. Director | Sale | −14,116 | $39.50 | $558K | 6,909,249 |
| 2025-10-24 | RA CAPITAL MANAGEMENT, L.P. Director | Sale | −122,271 | $39.50 | $4.8M | 747,380 |
| 2025-10-24 | RA CAPITAL MANAGEMENT, L.P. Director | Sale | −66,672 | $39.50 | $2.6M | 2,257,826 |
| 2025-10-24 | RA CAPITAL MANAGEMENT, L.P. Director | Sale | −107,941 | $39.50 | $4.3M | 219,867 |
| 2025-10-21 | Cloonan Michael President & CEO | Option exercise 10b5-1 | +13,324 | $6.11 | $81K | 560,667 |
| 2025-10-21 | Cloonan Michael President & CEO | Sale 10b5-1 | −13,324 | $34.44 | $459K | 547,343 |
| 2025-10-21 | Cloonan Michael President & CEO | Option exercise 10b5-1 | +30,049 | $6.11 | $184K | 577,392 |
| 2025-10-21 | Cloonan Michael President & CEO | Sale 10b5-1 | −30,049 | $35.63 | $1.1M | 547,343 |
| 2025-10-21 | Cloonan Michael President & CEO | Option exercise 10b5-1 | +22,895 | $6.11 | $140K | 570,238 |
| 2025-10-21 | Cloonan Michael President & CEO | Sale 10b5-1 | −22,895 | $36.60 | $838K | 547,343 |
| 2025-10-21 | Cloonan Michael President & CEO | Option exercise 10b5-1 | +33,532 | $6.11 | $205K | 580,875 |
| 2025-10-21 | Cloonan Michael President & CEO | Sale 10b5-1 | −33,532 | $37.31 | $1.3M | 547,343 |
| 2025-10-21 | Cloonan Michael President & CEO | Option exercise · Non-Qualified Stock Option (right to buy) 10b5-1 | −13,324 | 139,618 | ||
| 2025-10-21 | Cloonan Michael President & CEO | Option exercise · Non-Qualified Stock Option (right to buy) 10b5-1 | −30,049 | 109,569 | ||
| 2025-10-21 | Cloonan Michael President & CEO | Option exercise · Non-Qualified Stock Option (right to buy) 10b5-1 | −22,895 | 86,674 | ||
| 2025-10-21 | Cloonan Michael President & CEO | Option exercise · Non-Qualified Stock Option (right to buy) 10b5-1 | −33,532 | 53,142 | ||
| 2025-10-21 | Booth Bruce Director | Sale 10b5-1 | −22,339 | $32.69 | $730K | 2,360,156 |
| 2025-10-21 | Booth Bruce Director | Sale 10b5-1 | −4,688 | $32.69 | $153K | 697,297 |
Page 7 of 15 · 284 trades